Skip to main content
. 2020 Dec 23;60(5):2631–2641. doi: 10.1007/s00394-020-02455-2

Table 3.

Minimally adjusted for age and country Cox Proportional Hazard Ratios (HR) by quartile for cardiovascular disease outcomes and all-cause mortality

CVD outcomes All-cause mortality
Q2 HR (95% CI) Q3 HR (95% CI) Q4 HR (95% CI) P Q2 HR (95% CI) Q3 HR (95% CI) Q4 HR (95% CI) p
Vitamin C 0.77 (0.54–1.11) 0.59 (0.40–0.87) 0.72 (0.50–1.04) 0.04 0.57 (0.43–0.75) 0.49 (0.37–0.66) 0.51 (0.39–0.68) < 0.001
Lycopene 0.86 (0.61–1.23) 0.79 (0.55–1.13) 0.56 (0.38–0.85) 0.006 0.69 (0.53–0.90) 0.53 (0.40–0.71) 0.51 (0.38–0.68) < 0.001
β-Carotene 0.59 (0.41–0.85) 0.77 (0.55–1.09) 0.40 (0.26–0.62) < 0.001 0.59 (0.46–0.77) 0.55 (0.42–0.72) 0.36 (0.26–0.49) < 0.001
α-Carotene 0.85 (0.60–1.20) 0.64 (0.44–0.93) 0.54 (0.36–0.82) 0.001 0.79 (0.62–1.02) 0.56 (0.42–0.74) 0.40 (0.29–0.56) < 0.001
β-Cryptoxanthin 0.85 (0.60–1.23) 0.81 (0.56–1.18) 0.67 (0.45–1.01) 0.06 0.39 (0.29–0.52) 0.47 (0.36–0.62) 0.30 (0.22–0.41) < 0.001
Zeaxanthin 0.97 (0.66–1.41) 0.87 (0.57–1.31) 1.02 (0.68–1.54) 0.97 0.48 (0.36–0.63) 0.45 (0.34–0.60) 0.36 (0.26–0.49) < 0.001
Lutein 0.77 (0.53–1.13) 0.77 (0.51–1.16) 0.78 (0.51–1.19) 0.27 0.67 (0.51–0.87) 0.48 (0.36–0.65) 0.40 (0.29–0.55) < 0.001
α-Tocophorol 0.84 (0.56–1.28) 1.21 (0.83–1.77) 1.32 (0.91–1.91) 0.049 0.53 (0.40–0.70) 0.65 (0.49–0.85) 0.62 (0.47–0.81) 0.002
γ-Tocophorol 1.17 (0.79–1.73) 1.25 (0.85–1.84) 1.14 (0.77–1.69) 0.50 0.83 (0.63–1.10) 0.88 (0.67–1.16) 0.78 (0.59–1.04) 0.13
Retinol 0.81 (0.56–1.19) 0.87 (0.60–1.26) 0.85 (0.58–1.23) 0.45 0.71 (0.54–0.94) 0.75 (0.57–0.98) 0.77 (0.58–1.01) 0.07
Mean SAS 0.77 (0.56–1.08) 0.68 (0.48–0.97) 0.67 (0.47–0.96) 0.02 0.52 (0.41–0.67) 0.36 (0.27–0.48) 0.37 (0.28–0.49) < 0.001

THR indicated for quarters 2, 3 and 4 are relative to the reference quarter 1

Q quarter, HR hazard ratio, CI confidence intervals, Mean SAS mean standardised antioxidant score, p p for trend